XML 27 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1Close
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Assets:    
Cash and cash equivalents $ 8,196 $ 12,945
Investments 3,259 2,778
Accounts receivable, net 35,227 27,276
Inventories 18,025 19,090
Assets held for sale 0 908
Other current assets 3,151 2,636
Total current assets 67,858 65,633
Long-term investments 23,019 21,096
Property and equipment, net 13,183 12,873
Operating lease right-of-use assets 17,252 17,872
Goodwill 91,272 78,150
Intangible assets, net 29,234 24,803
Separate accounts assets 3,250 3,228
Other assets 4,660 4,620
Total assets 249,728 228,275 Close
Liabilities:    
Accounts payable 14,897 14,838
Pharmacy claims and discounts payable 22,874 19,423
Health care costs payable 12,049  
Health care costs payable   10,142
Policyholders’ funds 1,326 1,500
Accrued expenses 22,189 18,745
Other insurance liabilities 1,141 1,089
Current portion of operating lease liabilities 1,741 1,678
Short-term debt 200 0
Current portion of long-term debt 2,772 1,778
Liabilities held for sale 0 228
Total current liabilities 79,189 69,421
Long-term operating lease liabilities 16,034 16,800
Long-term debt 58,638 50,476
Deferred income taxes 4,311 4,016
Separate accounts liabilities 3,250 3,228
Other long-term insurance liabilities 5,459 5,835
Other long-term liabilities 6,211 6,730
Total liabilities 173,092 156,506 Close
Commitments and contingencies (Note 18)
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,768 shares issued and 1,288 shares outstanding at December 31, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplus 48,992 48,193
Treasury stock, at cost: 480 and 458 shares at December 31, 2023 and 2022 (33,838) (31,858)
Retained earnings 61,604 56,398
Accumulated other comprehensive loss (297) (1,264)
Total CVS Health shareholders’ equity 76,461 71,469
Noncontrolling interests 175 300
Total shareholders’ equity 76,636 71,769 Close
Total liabilities and shareholders’ equity $ 249,728 $ 228,275